272
Views
1
CrossRef citations to date
0
Altmetric
Review Articles

Talc and human cancer: a systematic review of the experimental animal and mechanistic evidence

, , , &
Pages 359-393 | Received 02 Apr 2024, Accepted 25 Apr 2024, Published online: 09 Jul 2024

References

  • Acencio MM, Vargas FS, Marchi E, Carnevale GG, Teixeira LR, Antonangelo L, Broaddus VC. 2007. Pleural mesothelial cells mediate inflammatory and profibrotic responses in talc-induced pleurodesis. Lung. 185(6):343–348. doi: 10.1007/s00408-007-9041-y.
  • Baiu I, Yevudza E, Shrager JB. 2019. Talc pleurodesis: a medical, medicolegal, and socioeconomic review. Ann Thorac Surg. 109(4):1294–1301. doi: 10.1016/j.anthroacsur.2019.08.104.
  • Beck BD, Feldman HA, Brain JD, Smith TJ, Hallock M, Gerson B. 1987. The pulmonary toxicity of talc and granite dust as estimated from an in vivo hamster bioassay. Toxicol Appl Pharmacol. 87(2):222–234. doi: 10.1016/0041-008x(87)90284-5.
  • Boobis AR, Doe JE, Heinrich-Hirsch B, Meek ME, Munn S, Ruchirawat M, Schlatter J, Seed J, Vickers C. 2008. IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit Rev Toxicol. 38(2):87–96. doi: 10.1080/10408440701749421.
  • Boon D, Goodman JE, Colonna KJ, Espira LM, Prueitt RL. 2024. A systematic review of the epidemiology evidence on talc and cancer. Crit Rev Toxicol. doi: 10.1080/10408444.2024.2351081.
  • Boorman GA, Seely JC. 1995. The lack of an ovarian effect of lifetime talc exposure in F344/N rats and B6C3F1 mice. Regul Toxicol Pharmacol. 21(2):242–243. doi: 10.1006/rtph.1995.1035.
  • Borm PJA. 2023. Talc inhalation in rats and humans: a review and appraisal of available evidence. J Occup Environ Med. 65(2):152–159. doi: 10.1097/JOM.0000000000002702.
  • Bus BJ. 2017. IARC use of oxidative stress as key mode of action characteristic for facilitating cancer classification: glyphosate case example illustrating a lack of robustness in interpretative implementation. Regul Toxicol Pharmacol. 86:157–166. doi: 10.1016/j.yrtph.2017.03.004.
  • Buz’Zard AR, Lau BH. 2007. Pycnogenol reduces talc-induced neoplastic transformation in human ovarian cell cultures. Phytother Res. 21(6):579–586. doi: 10.1002/ptr.2117.
  • Carr CJ. 1995. Talc: consumer uses and health perspectives. Regul Toxicol Pharmacol. 21(2):211–215. doi: 10.1006/rtph.1995.1030.
  • Coggiola M, Bosio D, Pira E, Piolatto PG, La Vecchia C, Negri E, Michelazzi M, Bacaloni A. 2003. An update of a mortality study of talc miners and millers in Italy. Am J Ind Med. 44(1):63–69. doi: 10.1002/ajim.10240.
  • Cramer DW, Welch WR, Berkowitz RS, Godleski JJ. 2007. Presence of talc in pelvic lymph nodes of a woman with ovarian cancer and long-term genital exposure to cosmetic talc. Obstet Gynecol. 110(2 Pt. 2):498–501. doi: 10.1097/01.AOG.0000262902.80861.a0.
  • De Boer CH. 1972. Transport of particulate matter through the human female genital tract. J Reprod Fertil. 28(2):295–297. doi: 10.1530/jrf.0.0280295.
  • Driscoll KE. 2022. Review of lung particle overload, rat lung cancer, and the conclusions of the Edinburgh Expert Panel – it’s time to revisit cancer hazard classifications for titanium dioxide and carbon black. Front Public Health. 10:907318. doi: 10.3389/fpubh.2022.907318.
  • Edelstam GA, Sjösten AC, Ellis H. 1997. Retrograde migration of starch in the genital tract of rabbits. Inflammation. 21(5):489–499. doi: 10.1023/A:1027307612999.
  • Egli GE, Newton M. 1961. The transport of carbon particles in the human female reproductive tract. Fertil Steril. 12:151–155. doi: 10.1016/s0015-0282(16)34084-5.
  • Endo-Capron S, Renier A, Janson X, Kheuang L, Jaurand MC. 1993. In vitro response of rat pleural mesothelial cells to talc samples in genotoxicity assays (sister chromatid exchanges and DNA repair). Toxicol In Vitro. 7(1):7–14. doi: 10.1016/0887-2333(93)90107-G.
  • Environment and Climate Change Canada and Health Canada. 2021. Screening assessment for talc (Mg3H2(SiO3)4) (Chemical Abstracts Service Registry Number 14807-96-6); [accessed 2024 Apr 24]. https://www.canada.ca/en/environment-climate-change/services/evaluating-existing-substances/screening-assessment-talc.html.
  • Fiume MM, Boyer I, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, et al. 2015. Safety assessment of talc as used in cosmetics. Int J Toxicol. 34(Suppl. 1):66S–129S. doi: 10.1177/1091581815586797.
  • Fletcher NM, Harper AK, Memaj I, Fan R, Morris RT, Saed GM. 2019. Molecular basis supporting the association of talcum powder use with increased risk of ovarian cancer. Reprod Sci. 26(12):1603–1612. doi: 10.1177/1933719119831773.
  • Ghio AJ, Soukup JM, Dailey LA, Richards JH, Turi JL, Pavlisko EN, Roggli VL. 2012. Disruption of iron homeostasis in mesothelial cells after talc pleurodesis. Am J Respir Cell Mol Biol. 46(1):80–86. doi: 10.1165/rcmb.2011-0168OC.
  • Goodman J, Lynch H. 2017. Improving the International Agency for Research on Cancer’s consideration of mechanistic evidence. Toxicol Appl Pharmacol. 319:39–46. doi: 10.1016/j.taap.2017.01.020.
  • Goodman JE, Kerper LE, Prueitt RL, Marsh CM. 2020. A critical review of talc and ovarian cancer. J Toxicol Environ Health B Crit Rev. 23(5):183–213. doi: 10.1080/10937404.2020.1755402.
  • Goodman JI. 1995. An analysis of the National Toxicology Program’s (NTP) Technical Report (NTP TR 421) on the toxicology and carcinogenesis studies of talc. Regul Toxicol Pharmacol. 21(2):244–249. doi: 10.1006/rtph.1995.1036.
  • Harper AK, Wang X, Fan R, Kirsch Mangu T, Fletcher NM, Morris RT, Saed GM. 2023. Talcum powder induces malignant transformation in normal human primary ovarian epithelial cells. Minerva Obstet Gynecol. 75(2):150–157. doi: 10.23736/S2724-606X.21.04989-7.
  • Heller DS, Westhoff C, Gordon RE, Katz N. 1996. The relationship between perineal cosmetic talc usage and ovarian talc particle burden. Am J Obstet Gynecol. 174(5):1507–1510. doi: 10.1016/S0002-9378(96)70597-5.
  • Henderson WJ, Hamilton TC, Baylis MS, Pierrepoint CG, Griffiths K. 1986. The demonstration of the migration of talc from the vagina and posterior uterus to the ovary in the rat. Environ Res. 40(2):247–250. doi: 10.1016/S0013-9351(86)80100-1.
  • Henderson WJ, Hamilton TC, Griffiths K. 1979. Talc in normal and malignant ovarian tissue. Lancet. 1(8114):499. doi: 10.1016/S0140-6736(79)90861-4.
  • Henderson WJ, Joslin CA, Turnbull AC, Griffiths K. 1971. Talc and carcinoma of the ovary and cervix. J Obstet Gynaecol Br Commonw. 78(3):266–272. doi: 10.1111/j.1471-0528.1971.tb00267.x.
  • Honda Y, Beall C, Delzell E, Oestenstad K, Brill I, Matthews R. 2002. Mortality among workers at a talc mining and milling facility. Ann Occup Hyg. 46(7):575–585. doi: 10.1093/annhyg/mef075.
  • [IARC] International Agency for Research on Cancer. 2010. IARC monographs on the evaluation of carcinogenic risks to humans volume 93: carbon black, titanium dioxide, and talc. International Agency for Research on Cancer (IARC), World Health Organization (WHO). IARC Monograph No. 93; [accessed 2024 Mar 29]. http://monographs.iarc.fr/ENG/Monographs/vol100C/mono93.pdf.
  • Ierardi AM, Urban A, Marsh GM. 2021. A quantitative weight of evidence assessment of Hill’s guidelines for causal inference for cosmetic talc as a cause of mesothelioma. Toxicol Appl Pharmacol. 417:115461. doi: 10.1016/j.taap.2021.115461.
  • [ILSI] ILSI Risk Science Institute Workshop Participants. 2000. The relevance of the rat lung response to particle overload for human risk assessment: a workshop consensus report. Inhal Toxicol. 12(1–2):1–17. doi: 10.1080/08958370050029725.
  • Johnson KE, Popratiloff A, Fan Y, McDonald S, Godleski JJ. 2020. Analytic comparison of talc in commercially available baby powder and in pelvic tissues resected from ovarian carcinoma patients. Gynecol Oncol. 159(2):527–533. doi: 10.1016/j.ygyno.2020.09.028.
  • Johnson NF. 2020. Inhalation toxicity of talc. J Aerosol Med Pulm Drug Deliv. 34(2):79–107. doi: 10.1089/jamp.2020.1609.
  • Keskin N, Teksen YA, Ongun EG, Ozay Y, Saygili H. 2009. Does long-term talc exposure have a carcinogenic effect on the female genital system of rats? An experimental pilot study. Arch Gynecol Obstet. 280(6):925–931. doi: 10.1007/s00404-009-1030-3.
  • Kunz G, Beil D, Deininger H, Wildt L, Leyendecker G. 1996. The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy. Hum Reprod. 11(3):627–632. doi: 10.1093/HUMREP/11.3.627.
  • Litton Bionetics, Inc. 1974. Mutagenic evaluation of talc. Rockville (MD): US Food and Drug Administration (US FDA); p. 144. Report Nos.: NTIS PB-245458, FDABF-GRAS-302.
  • Lynch HN, Lauer DJ, Leleck OM, Freid RD, Collins J, Chen K, Thompson WJ, Ierardi AM, Urban A, Boffetta P, et al. 2023. Systematic review of the association between talc and female reproductive tract cancers. Front Toxicol. 5:1157761. doi: 10.3389/ftox.2023.1157761.
  • Lynch HN, Lauer DJ, Thompson WJ, Leleck O, Freid RD, Collins J, Chen K, Ierardi AM, Urban AM, Cappello MA, et al. 2022. Systematic review of the scientific evidence of the pulmonary carcinogenicity of talc. Front Public Health. 10:989111. doi: 10.3389/fpubh.2022.989111.
  • Mandarino A, Gregory DJ, McGuire CC, Leblanc BW, Witt H, Rivera LM, Godleski JJ, Fedulov AV. 2020. The effect of talc particles on phagocytes in co-culture with ovarian cancer cells. Environ Res. 180:108676. doi: 10.1016/j.envres.2019.108676.
  • McDonald SA, Fan Y, Welch WR, Cramer DW, Godleski JJ. 2019. Migration of talc from the perineum to multiple pelvic organ sites. Am J Clin Pathol. 152(5):590–607. doi: 10.1093/ajcp/aqz080.
  • McDonald SA, Fan Y, Welch WR, Cramer DW, Stearns RC, Sheedy L, Katler M, Godleski JJ. 2019. Correlative polarizing light and scanning electron microscopy for the assessment of talc in pelvic region lymph nodes. Ultrastruct Pathol. 43(1):13–27. doi: 10.1080/01913123.2019.1593271.
  • Meek ME, Palermo CM, Bachman AN, North CM, Lewis RJ. 2014. Mode of action human relevance (species concordance) framework: evolution of the Bradford Hill considerations and comparative analysis of weight of evidence. J Appl Toxicol. 34(6):595–606. doi: 10.1002/jat.2984.
  • Miller E, Beckett EM, Cheatham D, Comerford CE, Lewis RC, Krevanko C, Mandava N, Pierce JS. 2024. A review of the mesotheliogenic potency of cleavage fragments found in talc. Toxicol Ind Health. 7482337241246924. doi: 10.1177/07482337241246924.
  • Morrow PE, Haseman JK, Hobbs CH, Driscoll KE, Vu V, Oberdörster G. 1996. The maximum tolerated dose for inhalation bioassays: toxicity vs overload. Fundam Appl Toxicol. 29(2):155–167. doi: 10.1093/toxsci/29.2.155.
  • Mostafa SA, Bargeron CB, Flower RW, Rosenshein NB, Parmley TH, Woodruff JD. 1985. Foreign body granulomas in normal ovaries. Obstet Gynecol. 66(5):701–702.
  • Mundt KA, Santamaria AB, Thompson WJ, Bates CA, Boles C, Dotson GS, Yong M. 2022. Carcinogenicity of poorly soluble low toxicity particles: commentary on epidemiology as a risk assessment "Reality Check". Front Public Health. 10:920032. doi: 10.3389/fpubh.2022.920032.
  • Musser SM. 2014. Letter to S. Epstein from University of Illinois. Chicago, Re: response to citizen petitions requesting that the Food and Drug Administration (FDA) require a cancer warning on cosmetic talc products. US Food and Drug Administration (US FDA). Report No.: 94P-0420, FDA-2008-P-0309-0001/CP.
  • [Netherlands RIVM] Netherlands National Institute of Public Health and the Environment. 2023. CLH report: proposal for harmonised classification and labelling for talc (Mg3H2(SiO3)4) (EC No.: 238-877-9; CAS No.: 14807-96-6) (version number: 2.0). Submitted to European Chemicals Agency (ECHA).
  • [NTP] National Toxicology Program. 1993. Toxicology and carcinogenesis studies of talc (CAS No. 14807-96-6) in F344/N rats and B6C3F1 mice (inhalation studies). Report No.: NTP Technical Report Series No. 421, NIH Publication No. 93-3152. 287.
  • [NTP] National Toxicology Program. 2015. Office of Health Assessment and Translation (OHAT). OHAT risk of bias rating tool for human and animal studies; [accessed 2024 Mar 29]. https://ntp.niehs.nih.gov/ntp/ohat/pubs/riskofbiastool_508.pdf.
  • [NTP] National Toxicology Program. 2021. Report on carcinogens. 15th ed.; [accessed 2024 Mar 29]. https://ntp.niehs.nih.gov/go/roc15.
  • [OECD] Organisation for Economic Co-operation and Development. 2018. OECD guideline for the testing of chemicals: carcinogenicity studies. Report No.: OECD/OCDE 451.
  • Oberdörster G. 1995a. Lung particle overload: implications for occupational exposures to particles. Regul Toxicol Pharmacol. 21(1):123–135. doi: 10.1006/rtph.1995.1017.
  • Oberdörster G. 1995b. The NTP talc inhalation study: a critical appraisal focused on lung particle overload. Regul Toxicol Pharmacol. 21(2):233–241.
  • Phillips JC, Young PJ, Hardy K, Gangolli SD. 1978. Studies on the absorption and disposition of 3H-labelled talc in the rat, mouse, guinea-pig and rabbit. Food Cosmet Toxicol. 16(2):161–163. doi: 10.1016/s0015-6264(78)80197-7.
  • Pierce JS, Riordan AS, Miller EW, Gaffney SH, Hollins DM. 2017. Evaluation of the presence of asbestos in cosmetic talcum products. Inhal Toxicol. 29(10):443–456. doi: 10.1080/08958378.2017.1392656.
  • Pott F, Huth F, Friedrichs KH. 1974. Tumorigenic effect of fibrous dusts in experimental animals. Environ Health Perspect. 9:313–315. doi: 10.1289/ehp.749313.
  • PRISMA. 2024a. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA); [accessed 2024 Mar 29]. https://www.prisma-statement.org.
  • PRISMA. 2024b. PRISMA for systematic review protocols (PRISMA-P); [accessed 2024 Mar 29]. http://www.prisma-statement.org/Extensions/Protocols.
  • Sanchez MS, McGrath-Koerner M, McNamee BD. 2023. Characterization of elongate mineral particles including talc, amphiboles, and biopyriboles observed in mineral derived powders: comparisons of analysis of the same talcum powder samples by two laboratories. Environ Res. 230:114791. doi: 10.1016/j.envres.2022.114791.
  • Sato E, McDonald SA, Fan Y, Peterson S, Brain JD, Godleski JJ. 2020. Analysis of particles from hamster lungs following pulmonary talc exposures: implications for pathogenicity. Part Fibre Toxicol. 17(1):20. doi: 10.1186/s12989-020-00356-0.
  • Shim I, Kim HM, Yang S, Choi M, Seo GB, Lee BW, Yoon BI, Kim P, Choi K. 2015. Inhalation of talc induces infiltration of macrophages and upregulation of manganese superoxide dismutase in rats. Int J Toxicol. 34(6):491–499. doi: 10.1177/1091581815607068.
  • Sjösten ACE, Ellis H, Edelstam GAB. 2004. Retrograde migration of glove powder in the human female genital tract. Hum Reprod. 19(4):991–995. doi: 10.1093/humrep/deh156.
  • Smith CJ, Perfetti TA, Hayes AW, Berry SC, Trosko JE, King JA, Goodman JI, Begley CG, Dayan A. 2021. Categorizing the characteristics of human carcinogens: a need for specificity. Arch Toxicol. 95(8):2883–2889. doi: 10.1007/s00204-021-03109-w.
  • Smith MT, Guyton KZ, Gibbons CF, Fritz JM, Portier CJ, Rusyn I, DeMarini DM, Caldwell JC, Kavlock RJ, Lambert P, et al. 2016. Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis. Environ Health Perspect. 124(6):713–721. doi: 10.1289/ehp.1509912.
  • Stenback F, Rowland J. 1978. Role of talc and benzo(a)pyrene in respiratory tumor formation. An experimental study. Scand J Respir Dis. 59(3):130–140.
  • Taher MK, Farhat N, Karyakina NA, Shilnikova N, Ramoju S, Gravel CA, Krishnan K, Mattison D, Wen SW, Krewski D. 2019. Critical review of the association between perineal use of talc powder and risk of ovarian cancer. Reprod Toxicol. 90:88–101. doi: 10.1016/j.reprotox.2019.08.015.
  • [US EPA] Environmental Protection Agency (US), Office of Research and Development (ORD), Center for Public Health and Environmental Assessment (CPHEA). 2022. ORD staff handbook for developing IRIS assessments. Washington (DC). Report No.: EPA/600/R-22/268.
  • [US FDA] US Food and Drug Administration, Center for Food Safety and Applied Nutrition (CFSAN). 2021. CFSAN Constituent Update: FDA releases data from the agency’s 2021 testing of talc-containing cosmetic products for asbestos; [accessed 2024 Apr 17]. https://www.fda.gov/food/cfsan-constituent-updates/fda-releases-data-agencys-2021-testing-talc-containing-cosmetic-products-asbestos.
  • [US FDA] US Food and Drug Administration, Center for Food Safety and Applied Nutrition (CFSAN). 2022. CFSAN constituent update: FDA releases data from the agency’s 2022 testing of talc-containing cosmetic products for asbestos; [accessed 2024 Apr 17]. https://www.fda.gov/food/cfsan-constituent-updates/fda-releases-data-agencys-2022-testing-talc-containing-cosmetic-products-asbestos.
  • [US FDA] US Food and Drug Administration, Center for Food Safety and Applied Nutrition (CFSAN). 2024. CFSAN constituent update: FDA releases data from the agency’s 2023 testing of talc-containing cosmetic products for asbestos; [accessed 2024 Apr 17]. https://www.fda.gov/cosmetics/cosmetics-news-events/fda-releases-data-agencys-2023-testing-talc-containing-cosmetic-products-asbestos.
  • Venter PF, Iturralde M. 1979. Migration of a particulate radioactive tracer from the vagina to the peritoneal cavity and ovaries. S Afr Med J. 55(23):917–999.
  • Wagner JC, Berry G, Cooke TJ, Hill RJ, Pooley FD, Skidmore JW. 1977. Animal experiments with talc. In: Walton WH, McGovern B, editors. Inhaled Particles IV 1977. Proceedings of an International Symposium Organized by the British Occupational Hygiene Society; Sep 22–26; Edinburgh. Elmsford (NY): Pergamon Press. p. 647–654.
  • Wagner JC, Berry G, Hill RJ, Skidmore JW, Pooley FD. 1979. An animal model for inhalation exposure to talc. In: Lemen R, Dement JM, editors. Dusts and disease: Proceedings of the Conference on Occupational Exposures to Fibrous and Particulate Dust and their Extension into the Environment. Park Forest South (IL): Pathotox Publishers, Inc.; p. 389–392.
  • Warheit DB, Kreiling R, Levy LS. 2016. Relevance of the rat lung tumor response to particle overload for human risk assessment – update and interpretation of new data since ILSI 2000. Toxicology. 374:42–59. doi: 10.1016/j.tox.2016.11.013.
  • Waspe J, Bui T, Dishaw L, Kraft A, Luke A, Beronius A. 2021. Evaluating reliability and risk of bias of in vivo animal data for risk assessment of chemicals – exploring the use of the SciRAP tool in a systematic review context. Environ Int. 146:106103. doi: 10.1016/j.envint.2020.106103.
  • Wehner AP, Hall AS, Weller RE, Lepel EA, Schirmer RE. 1985. Do particles translocate from the vagina to the oviducts and beyond? Food Chem Toxicol. 23(3):367–372.
  • Wehner AP, Tanner TM, Buschbom RL. 1977. Absorption of ingested talc by hamsters. Food Cosmet Toxicol. 15(5):453–455. doi: 10.1016/S0015-6264(77)80013-8.
  • Wehner AP, Weller RE, Lepel EA. 1986. On talc translocation from the vagina to the oviducts and beyond. Food Chem Toxicol. 24(4):329–338. doi: 10.1016/0278-6915(86)90011-6.
  • Wehner AP, Wilkerson CL, Cannon WC, Buschbom RL, Tanner TM. 1977. Pulmonary deposition, translocation and clearance of inhaled neutron-activated talc in hamsters. Food Cosmet Toxicol. 15(3):213–224. doi: 10.1016/S0015-6264(77)80392-1.
  • Wehner AP, Zwicker GM, Cannon WC. 1977. Inhalation of talc baby powder by hamsters. Food Cosmet Toxicol. 15(2):121–129. doi: 10.1016/S0015-6264(77)80317-9.
  • Wehner AP. 2002. Cosmetic talc should not be listed as a carcinogen: comments on NTP's deliberations to list talc as a carcinogen. Regul Toxicol Pharmacol. 36(1):40–50. doi: 10.1006/rtph.2002.1560.
  • Wild P, Leodolter K, Réfrégier M, Schmidt H, Zidek T, Haidinger G. 2002. A cohort mortality and nested case-control study of French and Austrian talc workers. Occup Environ Med. 59(2):98–105. doi: 10.1136/oem.59.2.98.
  • Wylie AG, Skinner HC, Marsh J, Snyder H, Garzione C, Hodkinson D, Winters R, Mossman BT. 1997. Mineralogical features associated with cytotoxic and proliferative effects of fibrous talc and asbestos on rodent tracheal epithelial and pleural mesothelial cells. Toxicol Appl Pharmacol. 147(1):143–150. doi: 10.1006/taap.1997.8276.